Features of Immunesenescence Present in Early Stages of Rheumatoid Arthritis
THURSDAY, Sept. 11, 2025 -- Some features of immunesenescence are present in the very early stages of rheumatoid arthritis (RA), according to a study published online Sept. 3 in eBioMedicine.
Karim Raza, B.M.B.Ch., Ph.D., from the University of Birmingham in the United Kingdom, and colleagues examined the presence of immunesenescence in the early stages of RA development, including in patients with clinically suspected arthralgia and undifferentiated arthritis. A total of 224 participants were recruited: 69 healthy controls; 32 with clinically suspected arthralgia; 44 with undifferentiated arthritis; 23 with newly presenting disease-modifying antirheumatic drug (DMARD)-naive RA and three months or less symptom duration; and 56 with DMARD-naive RA and more than three months symptom duration.
The researchers found that patients with arthralgia or undifferentiated arthritis had reduced frequencies of naive CD4 T cells and recent thymic emigrants. Only once RA was established were other features of immunesenescence seen, including raised frequency of Th17, Tregs, and senescent-like T cells. In patients during early stages of the disease, the IMM-AGE (immuno-aging) score and other hallmarks of aging (inflammation, autophagic defects) were elevated. In patients with arthralgia, there was evidence of immunesenescence features as a predictor of RA development.
"We've discovered that immune aging isn't just a consequence of rheumatoid arthritis -- it may be a driver of the disease itself," senior author Niharika Duggal, also from the University of Birmingham, said in a statement. "We found that people in the early stages of rheumatoid arthritis, i.e. before a clinical diagnosis, show signs of faster immune system aging."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Cancer Survival Lower in Rural Areas
WEDNESDAY, Oct. 1, 2025 -- Five-year cancer survival rates for each stage of cancer (localized, regional, and distant) is lower in nonmetropolitan areas for Black and White...
Loss of Smell May Linger After COVID-19
WEDNESDAY, Oct. 1, 2025 -- Self-reported change or loss in smell or taste is an accurate signal of verified hyposmia after COVID-19, although there is also a high rate of hyposmia...
Elderly Patients Benefit From Screening Mammography
WEDNESDAY, Oct. 1, 2025 -- Patients with breast cancer diagnosed at 80 years of age or older who received screening mammography present with earlier-stage disease and have better...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.